Feedback / Questions
AEF0117 - Indivior
https://www.businesswire.com/news/home/20250326193712/en/Aelis-Farma-Announces-the-Final-Analysis-of-the-Landmark-Phase-2B-Clinical-Trial-in-Cannabis-Use-Disorder-CUD-with-the-CB1-SSi-AEF0117
Mar 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next